197376, Санкт-Петербург, ул. Акад. Павлова, д. 12,
Институт экспериментальной медицины РАМН
Тел.: (812) 234 16 69, +7 921 984 11 30, +7 921 909 55 49
Факс: (812) 234 94 89
E-mail:
Web: cytokines.ru

  

Columns list | Next column | Previous column

PRACTITIONER ADVISOR

• Number 4'2002
  • Recombinant IL-2 (Roncoleukin) in treatment of chronic viral C hepatitis patients
    L.Ph. Sklyar, E.V. Markelova

  • Effect of Glutoxim on the development and course of inflammation in experimental tuberculosis
    G.N. Mozhokina, N.A. Elistratova, L.P. Mikhailova, A.D. Kunitchan

• Number 1'2003
  • Impairment of immunity in recurrent furunculosis
    N.M. Kalinina

  • Immune mechanisms in acute liver steatosis of pregnant
    R.E. Niazmetov, A.P. Rhizopulu

• Number 3'2003
  • Immunocorrection in recurrent Yersinia pseudotuberculosis infection in children
    S.N. Beniova, E.V. Markelova

  • Diagnostic value of cytokine studies in clinical practice
    A.V. Demyanov, A.Yu. Kotov, A.S. Simbirtsev

• Number 4'2003
  • Aetiological role of human papilloma virus in cervical cancer development: genetic and pathogenesis aspects
    V.I. Kiselev, O.I. Kiselev

  • Inflammation in patients with chronic pancreatitis: the role of tumor-necrosis factor, interleukins 4 and 10
    T.I. Dolgikh, N.V. Shirinskaya, N.G. Gordienko, T.F. Sokolova

  • Reaferon-EC®-Lipint in an urgent prophylaxis of influenza-like virus diseases
    M.K. Yerofeeva, V.L. Maksakova, I.L. Kolyvanova, A.S. Schadrin, A.A. Kolokoltsev, V.M. Nikolaeva, E.M. Voitsechovskaya

• Number 1'2004
  • Reaferon-EC®-Lipint Liposomalis in treatment of influenza and other acute respiratory virus infections
    Y.V. Lobzin, N.I. Lvov, A.A. Kolokoltsov

• Number 2'2004
  • Neuroimmunomodulatory properties of Cerebrolysin
    N.Yu. Sotnikova, O.A. Gromova, E.A. Novikova

  • The role of cytokines in acute surgical abdominal pathology
    S.V. Minaev

• Number 3'2004
  • Immunomodulator Polyoxidonium: mechanisms of action and aspects of clinical application
    B.V. Pinegin, A.V. Nekrasov, R.M. Khaitov

  • Mechanisms of inflammatory reaction and proteolytic enzymes influence upon them
    M. Lysikova, M. Wald, Z. Masinovsky

• Number 4'2004
  • Th phenotype of immune response as a risk factor for bronchial asthma development in toddlers
    Belan E.B.

  • A case of Betaleukin application in treatment of genital tuberculosis in a woman
    K.V. Shalygin

• Number 4'2005
  • Cytokine network as a target for systemic enzyme therapy
    G.Ju. Knorring

• Number 1'2006
  • Good's syndrome - the primary immunodeficiency with late clinical manifestations. Literature review and own data
    N.M. Kalinina, V.G. Pischik, N.I. Davidova

• Number 3'2006
  • Clinical and immunological parallels in patients with ischemic stroke at the early rehabilitation stage
    L.F. Chernetsova, T.V. Zhuravel

• Number 4'2006
  • Immunological aspects of acute destructive pancreatitis pathology and correction of impairments with recombinant IL-2
    S.V. Salienko, E.V. Markelov , B.A. Sotnichenko

  • Systemic enzyme therapy in management of infective endocarditis in drug addicts
    V.I. Ulanova, V.I. Mazurov

  • The levels of anti-inflammatory cytokines in evaluation of inflammatory process activity in bronchial-pulmonary pathology in children
    Y.S. Guschina, L.N. Kassner, E.V. Markelova, A.I. Itskovich

  • Efficiency of recombinant IL-1b for treatment of suppurative destructive diseases of lungs and pleura
    A.V. Salamatov, O.V. Barinov, A.G. Sinenchenko, E.A. Varyushina, V.G. Konusova, A.S. Simbirtsev

• Number 1'2007
  • Influence of prospidin on cytokine synthesis and lymphocyte functional activity in culture
    A.V. Petrov, N.V. Pigareva, S.A. Emelyanov, A.S. Simbirtsev

  • Effects of immunomodulator Bestim on spontaneous and induced production of cytokines IFNγ, IL-1β, IL-4, IL-8, IL-10 by blood immunocompetent cells of healthy humans in vitro
    V.A. Zurochka, I.I. Dolgushin, A.S. Simbirtsev

  • Influence of Bestim immunomodulator on clinical and immunological parameters in patients with idiopathic inflammatory myopathy
    T.M. Alexeeva, N.V. Shabashova, E.V. Frolova, A.A. Kolobov, A.S. Simbirtsev

  • Immune and cytokine profile of chronic hepatitis C patients under the use of antiviral agent Panavir and immunomodulator Galavit
    Yu.V. Red'kin, E.V. Dron

  • Latent herpes infection reactivation in acute ischemic stroke and its correction with cerebrolysin
    A.E. Kulchikov, A.N. Makarenko

• Number 2'2007
  • Peculiarities of immune regulation in case of intensive physical activity
    Yu.I. Sternin, G.Yu. Knorring, L.P. Siziakina

  • Vilon efficiency in patients with maxillofacial phlegmons
    Yu.I. Pinelis, I.S. Pinelis, V.V. Malinin, V.G. Morozov, B.I. Kuznik

  • Wound healing and local immunostimulatory activity of recombinant human IL-1beta in patients with non-healing wounds and trophic leg ulcers
    E.A. Variouchina, V.V. Moskalenko, A.S. Simbirtsev, T.P. Lebedeva, A.N. Bubnov

• Number 3'2007
  • The influence of Bestim (SCV-07) on T-cell differentiation in mice
    A.V. Petrov, N.V. Pigareva, A.Yu. Kotov, A.A. Kolobov, A.S. Simbirtsev

  • Interferons and other cytokines in acute viral hepatitis C
    F.I. Yershov, M.V. Mezentseva

• Number 4'2007
  • Dynamic changes of humoral immunity in patients with chronic obstructivepulmonary diseases under the influence of immunocorrection
    T.A. Kuznetsova, M.F. Kinaykin, E.D. Buyakova, L.G. Semenovich, G.I. Sukhanova, N.N. Besednova, L.M. Epshtein

  • Evaluation of Betaleukin clinical effectiveness and immunomodulatory activity in primarily diagnosed tuberculosis patients
    O.P. Poddubnyak, L.A. Galizky, A.S. Simbirtsev, A.V. Stepanov

  • Immunopathogenesis of nervous system disorder developmentduring tick-borne infections in children
    T.V. Poponnikova, T.U. Bedareva, T.N. Vachrameeva, O.S. Pinevich, G.U. Galieva

Columns list | Next column | Previous column